These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28986246)

  • 1. Sphingosine 1-phosphate alleviates Coxsackievirus B3-induced myocarditis by increasing invariant natural killer T cells.
    Wang X; Yu Y; Li M; Yu Y; Liu G; Xie Y; Liu Y; Yang X; Zou Y; Ge J; Chen R
    Exp Mol Pathol; 2017 Oct; 103(2):210-217. PubMed ID: 28986246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The frequency of invariant natural killer T cells correlates with the severity of myocarditis.
    Wang X; Li M; Xie Y; Yu Y; Liu G; Yu Y; Yang X; Zou Y; Ge J; Chen R
    Viral Immunol; 2014 Apr; 27(3):88-95. PubMed ID: 24702483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTY720 alleviates coxsackievirus B3-induced myocarditis and inhibits viral replication through regulating sphingosine 1-phosphate receptors and AKT/caspase-3 pathways.
    Wang X; Li M; Yu Y; Liu G; Yu Y; Zou Y; Ge J; Chen R
    J Cell Physiol; 2019 Aug; 234(10):18029-18040. PubMed ID: 30843214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Galactosylceramide protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis.
    Wu CY; Feng Y; Qian GC; Wu JH; Luo J; Wang Y; Chen GJ; Guo XK; Wang ZJ
    Clin Exp Immunol; 2010 Oct; 162(1):178-87. PubMed ID: 20726989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
    Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
    Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.
    Tschöpe C; Müller I; Xia Y; Savvatis K; Pappritz K; Pinkert S; Lassner D; Heimesaat MM; Spillmann F; Miteva K; Bereswill S; Schultheiss HP; Fechner H; Pieske B; Kühl U; Van Linthout S
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
    Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
    Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
    Zhou L; He X; Gao B; Xiong S
    J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-37 Ameliorates Coxsackievirus B3-induced Viral Myocarditis by Modulating the Th17/Regulatory T cell Immune Response.
    An B; Liu X; Li G; Yuan H
    J Cardiovasc Pharmacol; 2017 May; 69(5):305-313. PubMed ID: 28207428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
    Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid ameliorates coxsackievirus-B3-induced viral myocarditis by modulating Th17/Treg imbalance.
    Jin H; Guo X
    Virol J; 2016 Oct; 13(1):168. PubMed ID: 27724948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A novel DNA vaccine containing endosome-fusogenic peptide prevents CVB3-induced myocarditis in mice].
    Xu W; Shen Y; Chen RZ; Xiong SD
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):334-8. PubMed ID: 15059520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of IL-2 inducible T-cell kinase alleviates T-cell activation and murine myocardial inflammation associated with CVB3 infection.
    He F; Yao H; Xiao Z; Han J; Zou J; Liu Z
    Mol Immunol; 2014 May; 59(1):30-8. PubMed ID: 24462896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex Hormone Contributes to Sexually Dimorphic Susceptibility in CVB3-Induced Viral Myocarditis via Modulating IFN-γ
    Zhou N; Yue Y; Xiong S
    Can J Cardiol; 2018 Apr; 34(4):492-501. PubMed ID: 29455951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA4-Ig relieves inflammation in murine models of coxsackievirus B3-induced myocarditis.
    Han B; Jiang H; Liu Z; Zhang Y; Zhao L; Lu K; Xi J
    Can J Cardiol; 2012; 28(2):239-44. PubMed ID: 22336520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coxsackievirus B3 infection induced viral myocarditis by regulating the expression pattern of chemokines in cardiac myocytes.
    Shen Y; Kan QC; Xu W; Chu YW; Xiong SD
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):1-9. PubMed ID: 19279353
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
    J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
    Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
    Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decay-accelerating factor (CD55) promotes CD1d expression and Vgamma4+ T-cell activation in coxsackievirus B3-induced myocarditis.
    Huber S; Song WC; Sartini D
    Viral Immunol; 2006; 19(2):156-66. PubMed ID: 16817758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose mercury heightens early innate response to coxsackievirus infection in female mice.
    Penta KL; Fairweather D; Shirley DL; Rose NR; Silbergeld EK; Nyland JF
    Inflamm Res; 2015 Jan; 64(1):31-40. PubMed ID: 25376339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.